3 Dividend Stocks to Buy and Hold Forever-Even After Their Latest Setbacks

Dividend dips matter less when the business model still works

A true "buy and hold forever" stock does not need to be perfect. It needs to keep generating cash, handling its obligations, and remaining capable of raising its dividend through ordinary economic ups and downs. That is why recent single-quarter setbacks can matter less than headlines suggest.

Bears do have a point: even dependable dividend stocks can stumble. Johnson & Johnson cut its 2026 profit forecast, and Coca-Cola missed fourth-quarter revenue estimates as consumers pushed back against price hikes. In the moment, those results can look like cracks in the story.

The stronger case, though, is that durable dividend growers prove themselves by getting through worse than one bad quarter. Dividend Aristocrats have increased payouts for at least 25 consecutive years through the dot-com crash, 2008, the pandemic, and changing rate environments. And the operating base still looks intact: NextEra Energy beat second-quarter adjusted profit on strength in renewables and higher power demand.

When headlines turn cold on dependable businesses, quality often gets mixed up with temporary noise. For investors building a long-term dividend portfolio, that can be an opportunity rather than a reason to hide.

Johnson & Johnson: reset in expectations, not in business strength

Johnson & Johnson's latest reset looks more like a thesis test than a thesis break. The company now expects 2026 adjusted EPS of $10.96 to $11.11, down from its earlier forecast of $11.60 to $11.75. That is a genuine cut, and it deserves respect. But it does not by itself make the business broken. J&J is still guiding to 2026 sales of $99.5 billion to $100.5 billion. A company still expected to generate roughly $100 billion in revenue is not suddenly losing its dividend backbone over a forecast reset.

The reset also appears tied to specific items rather than a broad collapse in demand. Reuters said the update reflected the combined financial impact of its newly completed acquisition of Firefly Bio and a strategic partnership with Sail Biomedicines. That reads more like integration and accounting effects than a failure of cash generation.

That view gets some support from J&J's earlier update last month, when management said it could still forecast 2026 profit of $11.43 to $11.63 per share while absorbing a hit of hundreds of millions of dollars from a drug pricing deal. Taken together, the lower guide looks more like a cleanup phase than a permanent damage event.

What investors should watch

For long-term holders, J&J does not need perfection. It needs evidence that its product portfolio and cash generation remain strong enough to support the dividend while management works through the reset.

Coca-Cola: pricing outran demand, but the brand still converts

Coca-Cola's stumble was familiar: price rose faster than consumers' willingness to pay. The company missed fourth-quarter revenue estimates after consumers pushed back against price hikes, and the near-term concern was a slower 2026. But that is not the same as a broken business model.

What the quarter actually showed

The problem was not that people suddenly stopped wanting Coke. It was that the pricing strategy got too ambitious for the moment. In a staples business, that is usually a management issue rather than an existential one. The fix is simpler pricing, more disciplined trade promotions, and time.

Just as important, Coke still appears to have pricing power. In its latest update, management raised its outlook to about 5% organic revenue growth from the prior 4% to 5% range, and lifted comparable EPS growth to 9% to 10% from 8% to 9%. That suggests the underlying demand engine is recovering rather than fading.

Why the dividend case still holds

A forever portfolio does not need a stock that never stumbles. It needs a business that can keep investing in the brand, protect shelf space, and return cash while the cycle resets. Coke's upgraded outlook suggests margin recovery as pricing normalizes, which is enough to keep the dividend case intact for now.

NextEra Energy: income plus a credible growth lane

J&J and Coke are better described as repair-and-hold stories right now. NextEra is different: it is the utility investors look to when they want income plus a real growth lane.

Why the quarter mattered

NextEra delivered $1.15 adjusted EPS versus a $1.11 analyst estimate, with Reuters citing strength in the renewables unit and higher power demand. NextEra Energy beat Wall Street estimates for second-quarter adjusted profit. One strong quarter does not prove a long-term growth thesis, but in a capital-intensive business, it does show that growth plans are still turning into earnings.

What could strengthen or weaken the case

• Bull case: NextEra is not just a bond-like utility. The beat came from operating momentum in renewables and demand, which leaves room for the stock to re-rate if earnings keep tracking with project execution and regulatory progress.
• Bear case: Utility investors still have to live with rate sensitivity and execution risk. If financing costs stay sticky or project timelines slip, the growth utility label becomes harder to defend.
• Watchpoints: The next earnings report should show continued strength in the renewables unit and support from higher power demand. If those drivers weaken, the growth premium becomes harder to justify.

For investors building a dividend portfolio with different roles, that makes NextEra the growth-leaning utility choice. J&J and Coke offer resilience through a reset; NextEra offers resilience with an active expansion engine.